Bandingkan Harga & Kinerja Lautan Luas Tbk. (LTLS) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Lautan Luas Tbk. dan Organon Pharma Indonesia Tbk.: Lautan Luas Tbk. diperdagangkan di Rp1.075 (kapitalisasi pasar 1,64 T, volume 24 jam 350,8 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Lautan Luas Tbk. jauh lebih besar — sekitar 15,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| LTLS | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 1,64 T | 104,4 M |
Volume | 350,8 rb | — |
Lot | 3,51 rb | — |
Perputaran | 373,61 jt | — |
Harga Rata-rata | 1.065,03 | — |
Nilai Transaksi | 373,61 jt | — |
Harga Ekuilibrium Indikatif | 1.075 | — |
Volume Ekuilibrium Indikatif | 9 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Lautan Luas Tbk.
PT Lautan Luas Tbk (the Company) was established under the name of Persekutuan Andil Maskapai Dagang dan Industri Lim Teck Lee Coy Ltd (Indonesia) based on notarial deed No. 75 dated January 18, 1951 of Raden Mas Soerojo. PT. Lautan Luas is a distributor and manufacturer - specialty and basic chemical.
Selengkapnya di halaman LTLS →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
